tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Argenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
Company AnnouncementsArgenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
6d ago
AGN
Argenica Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Argenica Therapeutics Announces Cessation of Securities
15d ago
AGN
Argenica Therapeutics Unveils Strategic Plans at Euroz Hartley’s Conference
PremiumCompany Announcements
Argenica Therapeutics Unveils Strategic Plans at Euroz Hartley’s Conference
1M ago
AGN
Argenica Therapeutics Announces Director Departure
PremiumCompany Announcements
Argenica Therapeutics Announces Director Departure
1M ago
AGN
Argenica Therapeutics Announces Director Resignation
PremiumCompany Announcements
Argenica Therapeutics Announces Director Resignation
1M ago
AGN
Argenica Therapeutics Reports Reduced Losses Amid Increased R&D Costs
PremiumCompany AnnouncementsArgenica Therapeutics Reports Reduced Losses Amid Increased R&D Costs
2M ago
AGN
Argenica’s ARG-007 Demonstrates Key Neuroprotective Effects in TBI Study
Premium
Company Announcements
Argenica’s ARG-007 Demonstrates Key Neuroprotective Effects in TBI Study
2M ago
AGN
Argenica Therapeutics Reports Promising Results for TBI Treatment
Premium
Company Announcements
Argenica Therapeutics Reports Promising Results for TBI Treatment
2M ago
AGN
Argenica’s Phase 2 Stroke Trial Proceeds with Positive Safety Review
PremiumCompany Announcements
Argenica’s Phase 2 Stroke Trial Proceeds with Positive Safety Review
3M ago
AGN
Argenica Therapeutics Advances Stroke Trial Progress
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Trial Progress
4M ago
AGN
Argenica Therapeutics Advances Phase 2 Stroke Trial
PremiumCompany Announcements
Argenica Therapeutics Advances Phase 2 Stroke Trial
6M ago
AGN
Argenica’s Clinical Trial Progress and Financial Health
PremiumCompany Announcements
Argenica’s Clinical Trial Progress and Financial Health
6M ago
AGN
Argenica Therapeutics Gains FDA Designations for ARG-006
PremiumCompany AnnouncementsArgenica Therapeutics Gains FDA Designations for ARG-006
6M ago
AGN
Argenica Therapeutics Schedules 2024 AGM
Premium
Company Announcements
Argenica Therapeutics Schedules 2024 AGM
6M ago
AGN
Argenica Therapeutics Bolsters Executive Team
Premium
Company Announcements
Argenica Therapeutics Bolsters Executive Team
6M ago
AGN
Argenica’s ARG-007 Shows Promise in Stroke Treatment
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promise in Stroke Treatment
7M ago
AGN
Argenica Therapeutics Welcomes New Director
PremiumCompany Announcements
Argenica Therapeutics Welcomes New Director
7M ago
AGN
Argenica Therapeutics Bolsters Board for Growth
PremiumCompany Announcements
Argenica Therapeutics Bolsters Board for Growth
7M ago
AGN
Argenica’s Stroke Trial Advances Unchanged
PremiumCompany Announcements
Argenica’s Stroke Trial Advances Unchanged
7M ago
AGN
Argenica Therapeutics Emphasizes Strong Governance
PremiumCompany AnnouncementsArgenica Therapeutics Emphasizes Strong Governance
8M ago
AGN
Argenica Therapeutics Strengthens Assets Despite Losses
Premium
Company Announcements
Argenica Therapeutics Strengthens Assets Despite Losses
8M ago
AGN
Argenica Therapeutics Director Acquires Options
Premium
Company Announcements
Argenica Therapeutics Director Acquires Options
8M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >